| 期 |
栏目 |
标题 |
文件 |
| 卷 78, 编号 5 (2003) |
Editorial |
Use of monoclonal antibodies to tumor necrosis factor (the drug remicade) in rheumatoid arthritis: pilot results |
|
| 卷 78, 编号 5 (2003) |
Editorial |
Effects of pulse-therapy on natural anticoagulant system of the endothelium in nonspecific aortoarteritis |
|
| 卷 78, 编号 5 (2003) |
Editorial |
Current approaches to prevention and treatment of antiphospholipid syndrome |
|
| 卷 78, 编号 5 (2003) |
Editorial |
Adhesion molecules in scleroderma systematica |
|
| 卷 79, 编号 5 (2004) |
Editorial |
Rheumatoid arthritis as a general medical problem |
|
| 卷 79, 编号 5 (2004) |
Editorial |
The level of TNF soluble receptor type 1 in patients with systemic sclerosis |
|
| 卷 79, 编号 5 (2004) |
Editorial |
Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome |
|
| 卷 79, 编号 1 (2004) |
Editorial |
Medical information-analytical center as an instrument of strategic and everyday planning in health service |
|
| 卷 79, 编号 5 (2004) |
Editorial |
Changes in inflammatory activity of rheumatoid arthritis at early stages of basic therapy with leflunomide |
|
| 卷 79, 编号 6 (2004) |
Editorial |
Detection of sodium monourate crystals in biopsies of gastric mucosa in gout patients |
|
| 卷 79, 编号 5 (2004) |
Editorial |
Immunoresistance syndrome in gout patients and its influence on formation of clinical features of the disease |
|
| 卷 79, 编号 12 (2004) |
Editorial |
Antibodies to cyclic citrullinized peptide in rheumatoid arthritis |
|
| 卷 80, 编号 5 (2008) |
Editorial |
Early diagnosis of rheumatoid arthritis in modern clinical practice (results of a follow-up of a Moscow cohort of early arthritis patients participating in the program RADICAL) |
|
| 卷 80, 编号 5 (2008) |
Editorial |
Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection |
|
| 卷 80, 编号 5 (2008) |
Editorial |
Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis |
|
| 卷 80, 编号 5 (2008) |
Editorial |
Behcet's disease and joint affection |
|
| 卷 80, 编号 8 (2008) |
Editorial |
Administration of monoclonal antibodies to b-lymphocytes (rituximab) in rheumatoid arthritis in Russia |
|
| 卷 81, 编号 6 (2009) |
Editorial |
Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions |
|
| 卷 81, 编号 6 (2009) |
Editorial |
Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis |
|
| 卷 81, 编号 5 (2009) |
Editorial |
Prophylaxis of cardiovascular diseases in rheumatoid arthritis |
|
| 卷 81, 编号 6 (2009) |
Editorial |
Combined treatment of gastric ulcers induced by nonsteroid anti-inflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate |
|
| 卷 81, 编号 6 (2009) |
Editorial |
Rituximab treatment of rheumatoid arthritis: new evidence |
|
| 卷 81, 编号 8 (2009) |
Editorial |
Clinical experience with infliximab administration in patients with rheumatoid arthritis by Russian register data |
|
| 卷 81, 编号 10 (2009) |
Editorial |
Relationship between the intima-media complex thickness, the risk factors of cardiovascular diseases, and the level of C-reactive protein in gouty patients |
|
| 卷 82, 编号 5 (2010) |
Editorial |
Rheumatic diseases: Current technologies and perspectives of laboratory diagnosis |
|
| 卷 82, 编号 5 (2010) |
Editorial |
New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor) |
|
| 卷 82, 编号 6 (2010) |
Editorial |
The first experience in using rituximab in Mikulicz's disease |
|
| 卷 83, 编号 5 (2011) |
Editorial |
Perspectives of the treatment of rheumatic diseases in the beginning of the XXI century |
|
| 卷 83, 编号 5 (2011) |
Editorial |
Ten-year risk of cardiovascular complications in patients with rheumatoid arthritis |
|
| 卷 83, 编号 5 (2011) |
Editorial |
Current knowledge about pathogenesis and treatment of arterial hypertension in rheumatoid arthritis |
|
| 卷 84, 编号 5 (2012) |
Editorial |
RHEUMATOID ARTHRITIS: PROBLEMS AND SIGNIFICANCE OF PERSONALIZED MEDICINE |
|
| 卷 84, 编号 5 (2012) |
Editorial |
TOCILIZUMAB IMPACT ON BLOOD CHOLESTERINE TRANSPORT AND EARLY MANIFESTATION OF ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS |
|
| 卷 84, 编号 5 (2012) |
Editorial |
FRAX-ASSISTED PREDICTION OF FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS |
|
| 卷 84, 编号 5 (2012) |
Editorial |
HCV-ASSOCIATED CRYOGLOBULINEMIC VASCULITIS |
|
| 卷 84, 编号 5 (2012) |
Editorial |
THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME |
|
| 卷 84, 编号 8 (2012) |
Editorial |
The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results |
|
| 卷 84, 编号 5 (2012) |
Editorial |
CURRENT TRENDS IN CLASSIFICATION AND TREATMENT OF SYSTEMIC VASCULITIS ASSOCIATED WITH ANTI-NEUTROPHILIC CYTOPLASMIC ANTIBODIES: RESULTS OF 2011 |
|
| 卷 84, 编号 7 (2012) |
Editorial |
Differential diagnosis of Wegener's granulomatosis and extranodal NK/T-cell lymphoma, nasal type |
|
| 卷 84, 编号 12 (2012) |
Editorial |
Rituximab therapy for systemic manifestations and MALT lymphomas of the parotid gland in Sjögren's disease: Preliminary data |
|
| 卷 85, 编号 2 (2013) |
Editorial |
IgG4-related disease: patient group characterization and rituximab therapy |
|
| 卷 85, 编号 1 (2013) |
Editorial |
Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome |
|
| 卷 85, 编号 5 (2013) |
Editorial |
Rheumatology in Russia in the early 21st century |
|
| 卷 85, 编号 5 (2013) |
Editorial |
The magnitude of fatigue and its association with depression, pain, and inflammatory activity in rheumatoid arthritis |
|
| 卷 85, 编号 5 (2013) |
Editorial |
Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis |
|
| 卷 85, 编号 5 (2013) |
Editorial |
Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab |
|
| 卷 85, 编号 8 (2013) |
Editorial |
Pharmacotherapy for rheumatoid arthritis in the early 21st century: Russian and international experience |
|
| 卷 85, 编号 5 (2013) |
Editorial |
Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis |
|
| 卷 86, 编号 5 (2014) |
Editorial |
Systemic autoimmune rheumatic diseases in 2013: Problems of laboratory diagnosis |
|
| 卷 86, 编号 5 (2014) |
Editorial |
Association between bone mineral density and erosive and destructive changes in patients with rheumatoid arthritis: Preliminary results |
|
| 卷 86, 编号 5 (2014) |
Editorial |
Cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy |
|
| 卷 86, 编号 5 (2014) |
Editorial |
Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases |
|
| 卷 86, 编号 5 (2014) |
Editorial |
Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment |
|
| 卷 86, 编号 5 (2014) |
Editorial |
Differential diagnosis of rheumatic diseases and blood cancers involving the nasal cavity and accessory sinuses |
|
| 卷 87, 编号 5 (2015) |
Editorial |
Rheumatic diseases and multimorbidity |
|
| 卷 87, 编号 5 (2015) |
Editorial |
Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy |
|
| 卷 87, 编号 5 (2015) |
Editorial |
Biological agents and fracture risk |
|
| 卷 87, 编号 11 (2015) |
Editorial |
Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study |
|
| 卷 87, 编号 12 (2015) |
Editorial |
IgG4-related disease and clonal B-cell lymphoid proliferation: Description of two clinical cases and a review of literature |
|
| 卷 88, 编号 5 (2016) |
Editorial |
Cardiovascular disease in rheumatic diseases |
(Rus)
|
| 卷 88, 编号 5 (2016) |
Editorial |
Relationship between matrix metalloproteinase-3 levels and articular destructive changes in early and extended rheumatoid arthritis |
(Rus)
|
| 卷 88, 编号 5 (2016) |
Editorial |
N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs |
(Rus)
|
| 卷 88, 编号 5 (2016) |
Editorial |
Current approaches to diagnosing and treating eosinophilic granulomatosis with polyangiitis: The 2015 international guidelines |
(Rus)
|
| 卷 88, 编号 5 (2016) |
Editorial |
Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis |
(Rus)
|
| 卷 88, 编号 12 (2016) |
Editorial |
Prospects for rheumatoid arthritis pharmacotherapy: New opportunities and recommendations |
(Rus)
|
| 卷 89, 编号 5 (2017) |
Editorial |
Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study |
(Rus)
|
| 卷 89, 编号 9 (2017) |
Editorial |
Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
Atherosclerosis: perspectives of anti-inflammatory therapy |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
Association of polymorphisms of HLA-DRB1 and TNF-308 G/A with radiographic joint damage in patients with early rheumatoid arthritis with high inflammatory activity, treated according to the principle of “Treat to target” (REMARKA study) |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
Efficacy and tolerability of abatacept treatment: results of 12 months observation |
(Rus)
|
| 卷 91, 编号 2 (2019) |
Editorial |
The use of Tofacitinib in the treatment of inflammatory bowel disease |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
Rheumatoid arthritis: achievements and unresolved issues |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
Chronic pain and depression in patients with rheumatoid arthritis: results of five - year follow - up |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
The role of laboratory biomarkers in monitoring of rituximab biosimilar therapy (Acellbia, “BIOCAD”) in patients with rheumatoid arthritis |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
The сhanges of bone mineral density on the risk of progression of osteoarthritis of the knee |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
New directions of pharmacotherapy of immune - inflammatory rheumatic diseases |
(Rus)
|
